D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3776
Avantis US Small Cap Equity ETF
AVSC
$3.03B
| $482K | ﹤0.01% |
7,740
| – | – |
2024 Q1
8 quarters
|
|
3777
PUT
BeOne Medicines Ltd
ONC
$40.9B
| $475K | ﹤0.01% |
1,600
-800
| -33% | -$259K |
2025 Q4
1 quarter
|
|
3778
First Trust Technology AlphaDEX Fund
FXL
$2.77B
| $474K | ﹤0.01% |
2,982
| – | – |
2024 Q1
8 quarters
|
|
3779
Mama's Creations
MAMA
$614M
| $473K | ﹤0.01% |
30,856
-19,659
| -39% | -$298K |
2024 Q3
6 quarters
|
|
3780
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$338M
| $473K | ﹤0.01% |
2,432
| – | – |
2025 Q2
3 quarters
|
|
3781
iShares MSCI Brazil Small-Cap ETF
EWZS
$322M
| $472K | ﹤0.01% |
31,853
-25,977
| -45% | -$376K |
2025 Q2
3 quarters
|
|
3782
Vaalco Energy
EGY
$635M
| $471K | ﹤0.01% |
74,253
-101,503
| -58% | -$512K |
2025 Q3
2 quarters
|
|
3783
CALL
Advance Auto Parts
AAP
$2.56B
| $469K | ﹤0.01% |
8,900
-1,800
| -17% | -$90.1K |
2025 Q2
3 quarters
|
|
3784
Forestar Group
FOR
$1.26B
| $469K | ﹤0.01% |
19,173
-66,216
| -78% | -$1.77M |
2023 Q3
10 quarters
|
|
3785
Phibro Animal Health
PAHC
$1.55B
| $468K | ﹤0.01% |
8,454
-55,120
| -87% | -$2.62M |
2025 Q2
3 quarters
|
|
3786
TriCo Bancshares
TCBK
$1.63B
| $467K | ﹤0.01% |
+9,828
| New | +$480K |
2026 Q1
0 quarters
|
|
3787
Cognex
CGNX
$9.19B
| $465K | ﹤0.01% |
9,495
-3,527
| -27% | -$165K |
2024 Q4
5 quarters
|
|
3788
CALL
Methanex
MEOH
$4.86B
| $465K | ﹤0.01% |
7,800
-1,900
| -20% | -$95.6K |
2025 Q2
3 quarters
|
|
3789
OR Royalties Inc
OR
$6.32B
| $464K | ﹤0.01% |
12,200
-36,018
| -75% | -$1.48M |
2024 Q3
6 quarters
|
|
3790
DELISTED
Day One Biopharmaceuticals
DAWN
| $464K | ﹤0.01% |
21,626
-293
| -1% | -$4.13K |
2022 Q2
15 quarters
|
|
3791
Brown & Brown
BRO
$22.7B
| $463K | ﹤0.01% |
7,100
-51,234
| -88% | -$3.69M |
2022 Q1
16 quarters
|
|
3792
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$113M
| $463K | ﹤0.01% |
15,296
-37,353
| -71% | -$1.15M |
2025 Q3
2 quarters
|
|
3793
CALL
Canopy Growth
CGC
$302M
| $460K | ﹤0.01% |
485,000
-268,700
| -36% | -$296K |
2024 Q2
7 quarters
|
|
3794
CTO Realty Growth
CTO
$777M
| $457K | ﹤0.01% |
+24,740
| New | +$461K |
2026 Q1
0 quarters
|
|
3795
Finance of America Companies
FOA
$106M
| $457K | ﹤0.01% |
27,508
+10,115
| +58% | +$209K |
2025 Q4
1 quarter
|
|
3796
PUT
Capri Holdings
CPRI
$1.73B
| $456K | ﹤0.01% |
25,900
-16,700
| -39% | -$353K |
2025 Q2
3 quarters
|
|
3797
State Street SPDR S&P Capital Markets ETF
KCE
$489M
| $456K | ﹤0.01% |
3,311
| – | – |
2024 Q4
5 quarters
|
|
3798
Global X Autonomous & Electric Vehicles ETF
DRIV
$333M
| $455K | ﹤0.01% |
14,899
-4,177
| -22% | -$133K |
2024 Q1
8 quarters
|
|
3799
PUT
Appian
APPN
$2.82B
| $453K | ﹤0.01% |
+18,800
| New | +$510K |
2026 Q1
0 quarters
|
|
3800
Abeona Therapeutics
ABEO
$258M
| $453K | ﹤0.01% |
101,065
-4,900
| -5% | -$24.5K |
2025 Q3
2 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.